This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in EMMESSAR BIOTECH & NUTRITION LTD.
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
- TAMBOLI CAPITAL LTD.
- INTERNATIONAL PAPER APPM
- GANESHA ECOSPHERE LTD.
- KABSONS INDUSTRIES LTD.
- SANATHNAGAR ENTERPRISES LIMITED
- POLYMAC THERMOFORMERS LTD
- SUERYAA KNITWEAR LTD
- BLUE CHIP INDIA LIMITED
- NORTHERN PROJECTS LIMITED
- XPRO INDIA LTD.
- SHRI BHOLANATH CARPETS LTD
- VEERAM SECURITIES LIMITED
- SMS LIFESCIENCES INDIA LTD
- POLY MEDICURE LTD.
- ISTREET NETWORK LIMITED
- SYNGENE INTERNATIONAL LTD
- PHOENIX INTERNATIONAL LTD.
- ADARSH MERCANTILE LIMITED
- SOURCE INDUSTRIES (INDIA) LTD.
- GRANULES INDIA LTD.
Frequently Asked Questions
What is the Share price of EMMESSAR BIOTECH & NUTRITION LTD. (EMMESSA)?
Can I buy EMMESSAR BIOTECH & NUTRITION LTD. (EMMESSA) shares?
How do I buy EMMESSAR BIOTECH & NUTRITION LTD. (EMMESSA) from Angel One?
- Direct investment: You can buy EMMESSAR BIOTECH & NUTRITION LTD. (EMMESSA) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to EMMESSAR BIOTECH & NUTRITION LTD. (EMMESSA) shares.
In which sector do EMMESSAR BIOTECH & NUTRITION LTD. (EMMESSA) belong?
Today's live share price for EMMESSAR BIOTECH & NUTRITION LTD. is NSE: N/A, BSE: ₹ 24.60 with a current market capitalization of .
Emmessar Biotech & Nutrition Ltd, originally started on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started with its operations manufacturing Super Specialty Fine Chemicals. In its in-house R&D, the Company succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated. ECIL`s research team established that the specialty chemicals made by them had potential as "Vital Micro Nutrients", used worldwide in research as "tools" of Biotechnology. The Company`s management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturer`s and consumer`s minds. To better represent its new core activity, a change in the company`s name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, became essential. EBNL`s R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well established and reputed in the USA. The intellectual exchange of concepts and technology between Emmessar Biotech & Nutrition Ltd., and Vibrant Life, led to path-breaking discoveries (VedaCeuticals) through a combination of core fundamentals of Nutraceuticals, Cosmeceuticals, Ayurveda, Biotechnology and Nanotechnology - giving a new dimension to future products emerging from the stable. EBNL`s range of products covers different aspects and unmet needs of Healthcare. They cater to and address obstinate skin problems, muscle problems, bone problems and other debilitating chronic physical ailments. EBNL is a Public Limited Company, with a paid-up Share Capital of about Rs. 50.00 million (over US$ 1.00 million). The Company`s stocks are traded on The Bombay Stock Exchange Ltd.Read more